The Readout: Speaking of Drug Prices image

STAT, October 12, 2016
Damian Garde and Meg Kesh, featuring Rachel Sachs (Academic Fellow alumna)


Read the full post

From the post:

How? Washington University law professor Rachel Sachs and Department of Veterans Affairs economist Austin Frakt suggest tying drug prices to cost-effectiveness. They'd also like society to pay more for preventive treatments and cures and less for lifelong treatments for chronic disease, in a bid to goad the industry to focus on developing treatments with more public benefit.

Read the full post here

fda health law policy pharmaceuticals public health regulation